Europe Medical Diagnostics Market (Immunoassays, Clinical Chemistry, Haematology & Coagulation): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,250	61 Pages	Koncept Analytics	March, 2024	KOAN18590440

Best Price Guarantee
Price	from $1,250
Length	61 Pages
Publisher	Koncept Analytics
Published Date	March, 2024
SKU	KOAN18590440

European medical diagnostics market is expected to reach US$109.91 billion in 2028, growing at a CAGR of 5.69%, for the time period of 2024-2028. Factors such as rise in number of new cancer cases, expansion of medical device industry, growth in geriatric population, accelerating demand for In-Vitro Diagnostic (IVD) and rapid urbanization would drive the growth of the market. However the market growth would be challenged by lack of skilled professionals, high cost of infectious diseases diagnosis and stringent government regulations. A few notable trends mat include, emerging role of precision medicine, emergence of various pandemic diseases and demand for point-of-care (POC) tests.

Based on technology, the market has been segmented into immunoassays, clinical chemistry, haematology and coagulation. With the development of signal generation methods, the attention has shifted to the development of immunochemical methods and instruments to provide convenient, high-performance systems. As a result of this, the demand for immunoassays is rising, which is aiding the market growth of medical diagnostics in Europe.

Based on country, the market has been segmented into Germany, the U.K., France and Rest of Europe. Due to the continuous collaboration and partnerships between diagnostics companies, along with the expansion of the healthcare infrastructure, Germany continues to be the dominant country, which is capturing significant share in the medical diagnostics market in Europe.

Scope of the report:

The report provides a comprehensive analysis of the European Medical Diagnostics Market.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The company profiles of leading players (Labcorp, Quest Diagnostics, Sonic Healthcare, Eurofins Scientific, Synlab and Medicover) are also presented in detail.

Key Target Audience:

Diagnostic Devices Manufacturers

Medical Technology Firms

End Users (Hospitals, Clinics, Emergency Centers, Home care, etc.)

Investment Banks

Healthcare and Medical Consultants

Government Bodies & Regulating Authorities

1. Overview: 1.1 Introduction; 1.2 Categories of Lab Testing; Table 1: Categories of Lab Testing; 1.3 Type of Diagnostic Products; Table 2: Type of Diagnostic Products; 1.4 Common Examples of Diagnostic Tests; Table 3: Common Examples of Diagnostic Tests; 1.5 Diagnosis of Infectious Diseases; 1.6 Conceptualization of Diagnosis Process; Table 4: Conceptualization of Diagnosis Process
2. Impact of COVID-19: 2.1 Increase in COVID-19 Tests; Table 5: Number of PCR Tests in Germany and France (2020); 2.2 Growth in Companies COVID-19 Sales; Table 6: Share of COVID-19 Sale in Companies’ Revenues (2020); 2.3 Demand for COVID-19 Self-test Kits
3. Europe Market Analysis: 3.1 Europe Medical Diagnostics Market by Value; Table 7: Europe Medical Diagnostics Market by Value (2019-2023); 3.2 Europe Medical Diagnostics Market Forecast by Value; Table 8: Europe Medical Diagnostics Market Forecast by Value (2024-2028); 3.3 Europe Medical Diagnostics Market by Technology; Table 9: Europe Medical Diagnostics Market by Technology (2023); 3.3.1 Europe Immunoassays Diagnostics Market by Value; Table 10: Europe Immunoassays Diagnostics Market by Value (2019-2023); 3.3.2 Europe Immunoassays Diagnostics Market Forecast by Value; Table 11: Europe Immunoassays Diagnostics Market Forecast by Value (2024-2028); 3.3.3 Europe Clinical Chemistry Diagnostics Market by Value; Table 12: Europe Clinical Chemistry Diagnostics Market by Value (2019-2023); 3.3.4 Europe Clinical Chemistry Diagnostics Market Forecast by Value; Table 13: Europe Clinical Chemistry Diagnostics Market Forecast by Value (2024-2028); 3.3.5 Europe Haematology Diagnostics Market by Value; Table 14: Europe Haematology Diagnostics Market by Value (2019-2023); 3.3.6 Europe Haematology Diagnostics Market Forecast by Value; Table 15: Europe Haematology Diagnostics Market Forecast by Value (2024-2028); 3.3.7 Europe Coagulation Diagnostics Market by Value; Table 16: Europe Coagulation Diagnostics Market by Value (2019-2023); 3.3.8 Europe Coagulation Diagnostics Market Forecast by Value; Table 17: Europe Coagulation Diagnostics Market Forecast by Value (2024-2028); 3.4 Europe Medical Diagnostics Market by Country; Table 18: Europe Medical Diagnostics Market by Region (2023); 3.4.1 Germany Medical Diagnostics Market by Value; Table 19: Germany Medical Diagnostics Market by Value (2019-2023); 3.4.2 Germany Medical Diagnostics Market Forecast by Value; Table 20: Germany Medical Diagnostics Market Forecast by Value (2024-2028); 3.4.3 The U.K. Medical Diagnostics Market by Value; Table 21: The U.K. Medical Diagnostics Market by Value (2019-2023); 3.4.4 The U.K. Medical Diagnostics Market Forecast by Value; Table 22: The U.K. Medical Diagnostics Market Forecast by Value (2024-2028); 3.4.5 France Medical Diagnostics Market by Value; Table 23: France Medical Diagnostics Market by Value (2019-2023); 3.4.6 France Medical Diagnostics Market Forecast by Value; Table 24: France Medical Diagnostics Market Forecast by Value (2024-2028)
4. Market Dynamics: 4.1 Growth Drivers; 4.1.1 Rise in Number of New Cancer Cases; Table 25: Incidence of New Cancer Cases in Europe by Types (2023); 4.1.2 Expansion of Medical Devices Industry; Table 26: Europe Medical Device Market (2020-2025); 4.1.3 Growth in Geriatric Population; Table 27: European Union Geriatric Population – Age 65 and Above (2017-2023); 4.1.4 Accelerating Demand for In-Vitro Diagnostic (IVD); Table 28: IVD Market Size by Top European Countries (2023); 4.1.5 Rapid Urbanization; Table 29: Europe Urban Population (2017-2023); 4.1.6 Growing Awareness About Various Infectious Diseases; 4.2 Key Trends and Developments; 4.2.1 Emerging Role of Precision Medicine; Table 30: Europe Precision Medicine Market (2021-2027); 4.2.2 Emergence of Various Pandemic Diseases; 4.2.3 Demand for Point-of-Care (POC) Tests; 4.3 Challenges; 4.3.1 Lack of Skilled Professionals; 4.3.2 High Cost of Infectious Diseases Diagnosis; 4.3.3 Stringent Government Regulations
5. Company Profiles: 5.1 Labcorp; 5.1.1 Business Overview; 5.2 Quest Diagnostics; 5.2.1 Business Overview; 5.3 Sonic Healthcare; 5.3.1 Business Overview; 5.4 Eurofins Scientific; 5.4.1 Business Overview; 5.5 Synlab; 5.5.1 Business Overview; 5.6 Medicover; 5.6.1 Business Overview

Clinical Chemistry and Immunoassay Industry, Global, 2023‒2028

October, 2024 | Published by: Frost & Sullivan | USD $4,950
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028

June, 2023 | Published by: MarketsandMarkets | USD $4,950
ASEAN Medical Diagnostics Market (Singapore, Malaysia, Indonesia, Thailand & Vietnam): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)

September, 2024 | Published by: Koncept Analytics | USD $1,250
US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)

March, 2024 | Published by: Koncept Analytics | USD $1,250
Global Immunoassay and Clinical Chemistry Analyzers Market Growth 2023-2029

May, 2023 | Published by: LP Information, Inc. | USD $3,660
Global Clinical Chemistry and Immunoassay Reagents Market Growth 2023-2029

May, 2023 | Published by: LP Information, Inc. | USD $3,660

Single User License:	$1,250
Global Site License:	$1,550

Europe Medical Diagnostics Market (Immunoassays, Clinical Chemistry, Haematology & Coagulation): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)